How Much Did AVAVA Medical Raise?
Funding & Key Investors

AVAVA Medical, a company specializing in advanced dermatology laser systems and AI-assisted skin imaging technology, has secured significant enterprise-level funding, with the total amount undisclosed as $54.6M. The company recently announced a major strategic investment of $19.6M, underscoring its pivotal role in the evolving medical aesthetics market.

What is AVAVA Medical?

AVAVA Medical
ManufacturingMedical Devices & Equipment

AVAVA Medical is at the forefront of cosmetic dermatology innovation, developing sophisticated laser systems and artificial intelligence-driven imaging technology. Their solutions are designed for a range of applications, including skin rejuvenation, pigmentation treatment, and addressing acne scars. The company's flagship platform, MIRIA, is an FDA-cleared image-guided laser treatment system that enhances the precision and efficacy of dermatological procedures, positioning AVAVA Medical as a key player in the high-growth medical aesthetics device sector.

How much funding has AVAVA Medical raised?

AVAVA Medical has raised a total of $54.6M across 3 funding rounds:

2024

Other Financing Round

$10M

Series C

$25M

2026

Private Equity

$19.6M

Other Financing Round (2024): $10M with participation from Catalio Capital Management

Series C (2024): $25M led by Jeisys Medical

Private Equity (2026): $19.6M, investors not publicly disclosed

Key Investors in AVAVA Medical

Catalio Capital Management

Catalio Capital Management is a New York-based investment firm specializing in innovative healthcare investing across private, public, and credit markets. They focus on breakthrough biomedical technology companies and invest in companies at all stages and sizes.

Jeisys Medical

Jeisys Medical is a leading K-beauty medical technology company specializing in advanced RF and energy-based aesthetic devices designed for providers, with a commitment to redefining the aesthetic device market through proven innovation.

What's next for AVAVA Medical?

The recent major strategic investment and the overall enterprise-level funding indicate a strong growth trajectory for AVAVA Medical. This capital infusion is expected to accelerate product development, expand market reach, and further enhance their AI capabilities. The company is poised to solidify its position by leveraging these resources to drive innovation in aesthetic dermatology, potentially leading to new device introductions and broader adoption of their existing technologies in both clinical and aesthetic settings.

See full AVAVA Medical company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Aerospace & DefenseManufacturing
Building MaterialsManufacturingFurniture
Industrial Machinery & EquipmentManufacturingAerospace & Defense
Health & Nutrition ProductsManufacturingRetailVitamins, Supplements & Health Stores

Frequently Asked Questions Regarding AVAVA Medical Financial Insights

What are the most recent funding rounds that AVAVA Medical has completed, and what were the funding rounds?
AVAVA Medical has recently completed 3 funding rounds: Private Equity on Mar 4, 2026, Series C on Jun 12, 2024, Other Financing Round on Jun 12, 2024.
What is the total amount of funding AVAVA Medical has raised to date?
AVAVA Medical has raised a total of $54.6M in funding to date.
How many funding rounds has AVAVA Medical completed?
AVAVA Medical has completed 3 funding rounds.
How much funding did AVAVA Medical raise in its most recent funding round?
AVAVA Medical raised $19.6M in its most recent funding round.
Which was the largest funding round in AVAVA Medical's history?
The largest funding round in AVAVA Medical's history was $25M.
See more information about AVAVA Medical